Mabosstiff ex do Arven #139 Pokemon Rivais Predestinados
Current Market Price
€0.30
(as of 11 Jul 2026, in Good condition)
DemandNumber of cards being soldUnknown
SupplyNumber of cards on the market right nowUnknown
LiquidityHow quickly you can expect to sell at the current market priceUnknown
Prices by Condition
estimated| Condition | Price |
|---|---|
| Near Mint | €0.77 |
| Excellent | €0.43 |
| Good | €0.30 |
| Light Played | €0.24 |
| Played | €0.19 |
| Poor | €0.13 |
€0.30
Good condition
DemandNumber of cards being soldUnknown
SupplyNumber of cards on the market right nowUnknown
LiquidityHow quickly you can expect to sell at the current market priceUnknown
Prices by Condition
estimated| Condition | Price |
|---|---|
| Near Mint | €0.77 |
| Excellent | €0.43 |
| Good | €0.30 |
| Light Played | €0.24 |
| Played | €0.19 |
| Poor | €0.13 |
No sales recorded in the last 90 days.
Card Information
- Pokemon
- Mabosstiff ex do Arven
- Number
- #139 / 182
- Set
- Rivais Predestinados
- Rarity
- Rara Dupla
- HP
- 270
- Type
- Sombrio
- Stage
- Estágio 1
- Evolves from
- Maschiff do Arven
- Retreat
- 3
- Illustrator
- akagi
- Regulation
- I
- Weakness
- Planta ×2
Investida Vigorosa
30+Se este Pokémon não tiver nenhum contador de dano nele, este ataque causará 120 pontos de dano a mais.
Cabeçada do Chefão
210Durante o seu próximo turno, este Pokémon não poderá usar Cabeçada do Chefão.
Market price overview for Mabosstiff ex do Arven #139 from Rivais Predestinados
Current pricing
The current market price for Mabosstiff ex do Arven (Rivais Predestinados) sits at €0.30 in Good condition. Expect to pay €0.77 for a Near Mint example.
Price history (90 days)
Price history shows Mabosstiff ex do Arven moving between €0.36 and €0.46 over the last 3 months. The price is mid-range right now.
Prices by condition
Want Mabosstiff ex do Arven in top shape (MT)? That'll cost €1. In PO condition, you can find it for just €0.13.
Buy or sell?
Mabosstiff ex do Arven is holding steady. There's no urgent reason to buy or sell based on current market conditions.
